Schedule 13D ownership disclosure
CONNECT BIOPHARMA HLDGS LTD
Security class unavailable · CUSIP: 207523101
Event date: 2023-11-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,955,011
- Percent of class
- 10.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-123294
- Form type
- SC 13D
- Filer
- Connect Biopharma Holdings Ltd
- CIK
- CIK 1835268
- Filed
- Dec 04, 2023
- Reporting period
- Nov 30, 2023
- Description
- Schedule 13D beneficial ownership